Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function

B. Teter, P. T. Xu, John Gilbert, A. D. Roses, D. Galasko, G. M. Cole

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The apolipoprotein E (apoE) epsilon 4 allele (apoE4) is a major risk factor for neurodegenerative conditions, including Alzheimer's disease (AD). A role for apoE in regeneration of synaptic circuitry after neural injury has been shown in several in vitro studies in which apoE3 supports neuronal sprouting better than apoE4. We evaluated sprouting in an in vitro mouse organotypic hippocampal slice culture system derived from transgenic mice expressing apoE3 or apoE4, in which apo E-dependent granule cell mossy fiber sprouting in the presence of apoE4 is only 51% of the level of apoE3. Sprouting supported by apoE4 had a dose response opposite that by supported by apoE3: although increasing E3 expression increased sprouting, increasing E4 expression decreased sprouting, suggesting that the defect in E4 in supporting neuronal sprouting is a gain-of-negative activity. These results may have important pharmacogenomic implications for AD therapies that modulate apoE expression levels.

Original languageEnglish
Pages (from-to)331-336
Number of pages6
JournalJournal of Neuroscience Research
Volume68
Issue number3
DOIs
StatePublished - May 1 2002
Externally publishedYes

Fingerprint

Apolipoprotein E4
Apolipoproteins E
Apolipoprotein E3
Alleles
Alzheimer Disease
Pharmacogenetics
Transgenic Mice
Regeneration
Wounds and Injuries

Keywords

  • Alzheimer's disease
  • Apolipoprotein E
  • Neurite sprouting
  • Transgenic mice

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Teter, B., Xu, P. T., Gilbert, J., Roses, A. D., Galasko, D., & Cole, G. M. (2002). Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. Journal of Neuroscience Research, 68(3), 331-336. https://doi.org/10.1002/jnr.10221

Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. / Teter, B.; Xu, P. T.; Gilbert, John; Roses, A. D.; Galasko, D.; Cole, G. M.

In: Journal of Neuroscience Research, Vol. 68, No. 3, 01.05.2002, p. 331-336.

Research output: Contribution to journalArticle

Teter, B, Xu, PT, Gilbert, J, Roses, AD, Galasko, D & Cole, GM 2002, 'Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function', Journal of Neuroscience Research, vol. 68, no. 3, pp. 331-336. https://doi.org/10.1002/jnr.10221
Teter, B. ; Xu, P. T. ; Gilbert, John ; Roses, A. D. ; Galasko, D. ; Cole, G. M. / Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. In: Journal of Neuroscience Research. 2002 ; Vol. 68, No. 3. pp. 331-336.
@article{2a8677cc39d8468cade740f2da6a1039,
title = "Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function",
abstract = "The apolipoprotein E (apoE) epsilon 4 allele (apoE4) is a major risk factor for neurodegenerative conditions, including Alzheimer's disease (AD). A role for apoE in regeneration of synaptic circuitry after neural injury has been shown in several in vitro studies in which apoE3 supports neuronal sprouting better than apoE4. We evaluated sprouting in an in vitro mouse organotypic hippocampal slice culture system derived from transgenic mice expressing apoE3 or apoE4, in which apo E-dependent granule cell mossy fiber sprouting in the presence of apoE4 is only 51{\%} of the level of apoE3. Sprouting supported by apoE4 had a dose response opposite that by supported by apoE3: although increasing E3 expression increased sprouting, increasing E4 expression decreased sprouting, suggesting that the defect in E4 in supporting neuronal sprouting is a gain-of-negative activity. These results may have important pharmacogenomic implications for AD therapies that modulate apoE expression levels.",
keywords = "Alzheimer's disease, Apolipoprotein E, Neurite sprouting, Transgenic mice",
author = "B. Teter and Xu, {P. T.} and John Gilbert and Roses, {A. D.} and D. Galasko and Cole, {G. M.}",
year = "2002",
month = "5",
day = "1",
doi = "10.1002/jnr.10221",
language = "English",
volume = "68",
pages = "331--336",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function

AU - Teter, B.

AU - Xu, P. T.

AU - Gilbert, John

AU - Roses, A. D.

AU - Galasko, D.

AU - Cole, G. M.

PY - 2002/5/1

Y1 - 2002/5/1

N2 - The apolipoprotein E (apoE) epsilon 4 allele (apoE4) is a major risk factor for neurodegenerative conditions, including Alzheimer's disease (AD). A role for apoE in regeneration of synaptic circuitry after neural injury has been shown in several in vitro studies in which apoE3 supports neuronal sprouting better than apoE4. We evaluated sprouting in an in vitro mouse organotypic hippocampal slice culture system derived from transgenic mice expressing apoE3 or apoE4, in which apo E-dependent granule cell mossy fiber sprouting in the presence of apoE4 is only 51% of the level of apoE3. Sprouting supported by apoE4 had a dose response opposite that by supported by apoE3: although increasing E3 expression increased sprouting, increasing E4 expression decreased sprouting, suggesting that the defect in E4 in supporting neuronal sprouting is a gain-of-negative activity. These results may have important pharmacogenomic implications for AD therapies that modulate apoE expression levels.

AB - The apolipoprotein E (apoE) epsilon 4 allele (apoE4) is a major risk factor for neurodegenerative conditions, including Alzheimer's disease (AD). A role for apoE in regeneration of synaptic circuitry after neural injury has been shown in several in vitro studies in which apoE3 supports neuronal sprouting better than apoE4. We evaluated sprouting in an in vitro mouse organotypic hippocampal slice culture system derived from transgenic mice expressing apoE3 or apoE4, in which apo E-dependent granule cell mossy fiber sprouting in the presence of apoE4 is only 51% of the level of apoE3. Sprouting supported by apoE4 had a dose response opposite that by supported by apoE3: although increasing E3 expression increased sprouting, increasing E4 expression decreased sprouting, suggesting that the defect in E4 in supporting neuronal sprouting is a gain-of-negative activity. These results may have important pharmacogenomic implications for AD therapies that modulate apoE expression levels.

KW - Alzheimer's disease

KW - Apolipoprotein E

KW - Neurite sprouting

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0036570338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036570338&partnerID=8YFLogxK

U2 - 10.1002/jnr.10221

DO - 10.1002/jnr.10221

M3 - Article

VL - 68

SP - 331

EP - 336

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 3

ER -